New Focus on Resilience

This past weekend the IMF convened the 20th annual Support Group Leaders Summit in Dallas, Texas. As usual, this was a highly emotional and successful event, bringing together 69 returning support group leaders, along with 31 leaders who participated for the first time. Congratulations to Robin Tuohy, IMF Vice President, Support Groups, and the entire IMF team for flawless planning and implementation. 

From the promise of immunotherapy to staying safe in the sun

At the International Myeloma Working Group (IMWG) Summit in June, the most active work group focused on immunotherapy, primarily CAR T-cell therapies and BiTEs (bi-specific T-cell engagers).

Cancer prevention back in the news

At the recent American Society of Clinical Oncology (ASCO) meeting in Chicago, the idea of preventing the progression of high-risk smoldering multiple myeloma to active myeloma using lenalidomide was a topic of active discussion. In this study that was presented at ASCO, the onset of active disease was clearly delayed. But is this “prevention” of myeloma? 

Prevention and the Search for a Cure Go Hand-in-Hand

Patients with active myeloma need the best treatment and, understandably, they are keenly interested in the search for a cure. But to prevent myeloma in the first place, we need a deep understanding of the disease. This understanding will lead to a world without myeloma by accelerating true disease eradication or cure.